4CX-22755-47166
2 vaccinations
3 coded responses
23 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 430 / OH
- Registered
- 2021-03-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-26
Dose 1 — Pfizer-BioNTech
-
2021-03-28
Registered in v-safe
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-09
-
2021-04-16
Dose 2 — Pfizer-BioNTech
- 2021-04-16
-
2021-04-17
Survey response — days 1–6 daily, dose 2MedDRA: Paraesthesia — Feeling: Fair · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: When I received the 2nd shot, I felt tingling in that arm.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-18
- 2021-04-19
- 2021-04-20
- 2021-04-21
- 2021-04-22
- 2021-04-23
- 2021-04-30
- 2021-05-07
- 2021-05-14
- 2021-05-21
- 2021-05-28
- 2021-07-16
-
2021-10-15
Survey response — 6 months, dose 2MedDRA: Condition aggravated, Office visit, Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: After my vaccine, I began to experience fibrocystic breast tenderness. It was so severe some months, and I had not experienced it since going on a hormone regulating med in 2014. My mammogram also required more images and ultrasound. Likely the shot. · Healthcare visit (other): Additional mammogram and ultrasound at (b)(6) CenterMedDRA releases: 2024-11 · check-in free text available
-
2021-10-15
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-10-25
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-04-16
Survey response — 12 months, dose 2MedDRA: Arthralgia, Fibrocystic breast disease, Nervous system disorder — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I have been having some strange nerve sensations in my hands, as well as a severe shoulder pain that came on suddenly and resolved suddenly within about 3 days. Severe fibrocystic breast tissue lasted for about 7 to 8 months, and then resolved.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-26 | Pfizer-BioNTech | |
| 2 | 2021-04-16 | Pfizer-BioNTech |
Call center
1 call center case
1 successful
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): When I received the 2nd shot, I felt tingling in that arm.
Release 10 — 6 months, dose 2
Symptoms: After my vaccine, I began to experience fibrocystic breast tenderness. It was so severe some months, and I had not experienced it since going on a hormone regulating med in 2014. My mammogram also required more images and ultrasound. Likely the shot. cut off by CDC
Healthcare visit (other): Additional mammogram and ultrasound at (b)(6) Center
redacted (b)(6)
Release 11 — 12 months, dose 2
Symptoms: I have been having some strange nerve sensations in my hands, as well as a severe shoulder pain that came on suddenly and resolved suddenly within about 3 days. Severe fibrocystic breast tissue lasted for about 7 to 8 months, and then resolved.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Condition aggravated | · | · | ✓ |
| SD | Fibrocystic breast disease | · | · | ✓ |
| SD | Nervous system disorder | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SRO | Paraesthesia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release